Tomonari Hamaguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tomonari Hamaguchi has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Nishiwaki
Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
2 shared publications - Jun-Ichi Takeda
Neurosurgery, Kansai Medical University, Hirakata, JPN
2 shared publications - Kinji Ohno
Graduate School of Nutritional Sciences, Nagoya University of Arts and Sciences
2 shared publications - Masaaki Hirayama
Department of Occupational Therapy, Chubu University College of Life and Health Sciences, Kasugai, Japan
2 shared publications - Mikako Ito
Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
2 shared publications - Misuzu Ohara
Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
2 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Elsevier in Neuroscience Research
- Vol. 231
Olfactory bulb–initiated α-synucleinopathy induces visual abnormalities via remote occipital network dysfunction
- 11 September 2026
- Published by Elsevier in Neuroscience Research
- Vol. 231
Open AccessOlfactory bulb–initiated α-synucleinopathy induces visual abnormalities via remote occipital network dysfunction
- Open Access
- 18 February 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2596809
Bacterial constipation: Mucin-degrading intestinal commensal bacteria cause constipation
The contribution of gut microbes to constipation remains mechanistically underexplored, despite constipation being one of the most prevalent gastrointestinal disorders. Here, we identify cooperative induction of constipation by two mucin-degrading gut commensals: Akkermansia muciniphila and Bacteroides thetaiotaomicron. In constipated patients with Parkinson's disease (PD) and chronic idiopathic constipation (CIC), we observed that A. muciniphila and B. thetaiotaomicron were increased. Gnotobiotic mice colonized with either bacterium exhibited no constipation, whereas mice co-colonized with both bacteria developed constipation. Fecal mucins but not gastric mucins carry terminal sulfates. As fecal transcriptome of gnotobiotic mice suggested a sulfatase-dependent mechanism, we generated an anaerobic sulfatase-maturating enzyme (anSME)-deficient B. thetaiotaomicron strain that cannot catabolize the terminal sulfates of mucins. In the absence of anSME, constipation was ameliorated in co-colonized gnotobiotic mice. The synergic effect of the two bacteria is in accordance with our observation that A. muciniphila alone and constipation are not correlated in humans. As a bunch of intestinal bacteria other than B. thetaiotaomicron also catabolize mucin sulfates, they may substitute for B. thetaiotaomicron in patients with constipation. We propose bacterial constipation, in which cooperative degradation of colonic mucins by sulfatases and glycosylases by two commensal bacteria reduces lubrication and induces fecal dehydration, leading to the development of constipation. Targeting microbial sulfatase activity may be a promising therapeutic approach for patients with bacterial constipation.
- 18 February 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2596809
Open AccessBacterial constipation: Mucin-degrading intestinal commensal bacteria cause constipation
The contribution of gut microbes to constipation remains mechanistically underexplored, despite constipation being one of the most prevalent gastrointestinal disorders. Here, we identify cooperative induction of constipation by two mucin-degrading gut commensals: Akkermansia muciniphila and Bacteroides thetaiotaomicron. In constipated patients with Parkinson's disease (PD) and chronic idiopathic constipation (CIC), we observed that A. muciniphila and B. thetaiotaomicron were increased. Gnotobiotic mice colonized with either bacterium exhibited no constipation, whereas mice co-colonized with both bacteria developed constipation. Fecal mucins but not gastric mucins carry terminal sulfates. As fecal transcriptome of gnotobiotic mice suggested a sulfatase-dependent mechanism, we generated an anaerobic sulfatase-maturating enzyme (anSME)-deficient B. thetaiotaomicron strain that cannot catabolize the terminal sulfates of mucins. In the absence of anSME, constipation was ameliorated in co-colonized gnotobiotic mice. The synergic effect of the two bacteria is in accordance with our observation that A. muciniphila alone and constipation are not correlated in humans. As a bunch of intestinal bacteria other than B. thetaiotaomicron also catabolize mucin sulfates, they may substitute for B. thetaiotaomicron in patients with constipation. We propose bacterial constipation, in which cooperative degradation of colonic mucins by sulfatases and glycosylases by two commensal bacteria reduces lubrication and induces fecal dehydration, leading to the development of constipation. Targeting microbial sulfatase activity may be a promising therapeutic approach for patients with bacterial constipation.
- Open Access
- 13 January 2025
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 75 (1) , 006636
Desulfovibrio falkowii sp. nov., Porphyromonas miyakawae sp. nov., Mediterraneibacter flintii sp. nov. and Owariibacterium komagatae gen. nov., sp. nov., isolated from human faeces
Small, obligately anaerobic strains 13CB8CT, 13CB11CT, 13CB18CT and 13GAM1GT were isolated from a faecal sample in a patient with Parkinson’s disease with a history of duodenal resection. After conducting a comprehensive polyphasic taxonomic analysis including genomic analysis, we propose the establishment of one new genus and four new species. The novel bacteria are Desulfovibrio falkowii sp. nov. (type strain JCM 36128T = DSM 116810T), Porphyromonas miyakawae sp. nov. (type strain JCM 36129T = DSM 116947T), Mediterraneibacter flintii sp. nov. (type strain JCM 36130T = DSM 116866T) and Owariibacterium komagatae gen. nov. sp. nov. (type strain JCM 36131T = DSM 116982T), respectively.
- 13 January 2025
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 75 (1) , 006636
Open AccessDesulfovibrio falkowii sp. nov., Porphyromonas miyakawae sp. nov., Mediterraneibacter flintii sp. nov. and Owariibacterium komagatae gen. nov., sp. nov., isolated from human faeces
Small, obligately anaerobic strains 13CB8CT, 13CB11CT, 13CB18CT and 13GAM1GT were isolated from a faecal sample in a patient with Parkinson’s disease with a history of duodenal resection. After conducting a comprehensive polyphasic taxonomic analysis including genomic analysis, we propose the establishment of one new genus and four new species. The novel bacteria are Desulfovibrio falkowii sp. nov. (type strain JCM 36128T = DSM 116810T), Porphyromonas miyakawae sp. nov. (type strain JCM 36129T = DSM 116947T), Mediterraneibacter flintii sp. nov. (type strain JCM 36130T = DSM 116866T) and Owariibacterium komagatae gen. nov. sp. nov. (type strain JCM 36131T = DSM 116982T), respectively.
- Open Access
- 1 July 2012
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 23 (13) , 2593-2604
The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration
Cell migration is essential for various physiological and pathological processes. Polarization in motile cells requires the coordination of several key signaling molecules, including RhoA small GTPases and phosphoinositides. Although RhoA participates in a front–rear polarization in migrating cells, little is known about the functional interaction between RhoA and lipid turnover. We find here that src-homology 2–containing inositol-5-phosphatase 2 (SHIP2) interacts with RhoA in a GTP-dependent manner. The association between SHIP2 and RhoA is observed in spreading and migrating U251 glioma cells. The depletion of SHIP2 attenuates cell polarization and migration, which is rescued by wild-type SHIP2 but not by a mutant defective in RhoA binding. In addition, the depletion of SHIP2 impairs the proper localization of phosphatidylinositol 3,4,5-trisphosphate, which is not restored by a mutant defective in RhoA binding. These results suggest that RhoA associates with SHIP2 to regulate cell polarization and migration.
- 1 July 2012
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 23 (13) , 2593-2604
Open AccessThe inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration
Cell migration is essential for various physiological and pathological processes. Polarization in motile cells requires the coordination of several key signaling molecules, including RhoA small GTPases and phosphoinositides. Although RhoA participates in a front–rear polarization in migrating cells, little is known about the functional interaction between RhoA and lipid turnover. We find here that src-homology 2–containing inositol-5-phosphatase 2 (SHIP2) interacts with RhoA in a GTP-dependent manner. The association between SHIP2 and RhoA is observed in spreading and migrating U251 glioma cells. The depletion of SHIP2 attenuates cell polarization and migration, which is rescued by wild-type SHIP2 but not by a mutant defective in RhoA binding. In addition, the depletion of SHIP2 impairs the proper localization of phosphatidylinositol 3,4,5-trisphosphate, which is not restored by a mutant defective in RhoA binding. These results suggest that RhoA associates with SHIP2 to regulate cell polarization and migration.